youtube_live
Q2 2026 daromadi • 4 kundan keyin
Tafsilotlarchevron_right
TWST:NASDAQ
Twist Bioscience Corp
58,45 US$
arrow_upward
+3,09%(+1,75) 1K
58,00 US$
arrow_downward
-0,77% (-0,45)bedtimeYopilgandan keyin
Savdolar yopilgan: 30-apr, 16:00:00 (GMT-4) · USD
search
Barcha belgilar
1K
5K
1O
6O
YBB
1Y
5Y
MAKS
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoTWST tikeri uchun statistika yaratilmoqda...
Ochish
57,50 US$
Yuqori
60,60 US$
Past
56,74 US$
Bozor kapitali
3,58 mlrd
Oʻrtacha hajm
1,18 mln
Hajmi
1,55 mln
52 haftalik eng yuqori
65,10 US$
52 haftalik eng past
23,30 US$
Aksiya boʻyicha daromad
-1,27 US$
Beta
2,21
Muomaladagi aksiyalar
61,31 mln
Xodimlar soni
979
Yangiliklar
Internetdagi manbalardan
Stock Titan
·
7 soat oldin
ARK Investment Management reports 10.35% stake in Twist Bioscience (NASDAQ: TWST)
Profil
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
Twist Bioscience Corp haqida
AI kontentda xatolar boʻlishi mumkin. Batafsil